Clinical Trial Update: Methylnaltrexone Use for Opioid-induced Postoperative Constipation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on Relistor (methylnaltrexone) for opioid-induced postoperative constipation. The study status is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• RELISTOR (methylnaltrexone)

Snippet

Sponsor: Shriners Hospitals for Children | Conditions: Constipation | Phase 4 | Status: COMPLETED